Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1925 1
1951 1
1954 1
1955 1
1956 1
1965 1
1966 2
1967 3
1968 2
1969 1
1971 5
1972 6
1973 1
1974 5
1975 1
1976 8
1977 3
1978 3
1979 4
1980 3
1981 3
1982 5
1983 6
1984 3
1985 7
1986 9
1987 8
1988 7
1989 3
1991 10
1992 8
1993 4
1994 5
1995 5
1996 13
1997 11
1998 15
1999 17
2000 16
2001 21
2002 19
2003 27
2004 25
2005 14
2006 23
2007 31
2008 36
2009 40
2010 65
2011 66
2012 60
2013 74
2014 77
2015 79
2016 82
2017 106
2018 107
2019 109
2020 114
2021 117
2022 107
2023 103
2024 100
2025 112

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,749 results

Results by year

Filters applied: . Clear all
Page 1
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.
Sahin U, Oehm P, Derhovanessian E, Jabulowsky RA, Vormehr M, Gold M, Maurus D, Schwarck-Kokarakis D, Kuhn AN, Omokoko T, Kranz LM, Diken M, Kreiter S, Haas H, Attig S, Rae R, Cuk K, Kemmer-Brück A, Breitkreuz A, Tolliver C, Caspar J, Quinkhardt J, Hebich L, Stein M, Hohberger A, Vogler I, Liebig I, Renken S, Sikorski J, Leierer M, Müller V, Mitzel-Rink H, Miederer M, Huber C, Grabbe S, Utikal J, Pinter A, Kaufmann R, Hassel JC, Loquai C, Türeci Ö. Sahin U, et al. Among authors: muller v. Nature. 2020 Sep;585(7823):107-112. doi: 10.1038/s41586-020-2537-9. Epub 2020 Jul 29. Nature. 2020. PMID: 32728218 Clinical Trial.
Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.
Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, Kurzeder C, Higgins MJ, Connolly RM, Baron-Hay S, Gión M, Guarneri V, Bianchini G, Wildiers H, Escrivá-de-Romaní S, Prahladan M, Bridge H, Kuptsova-Clarkson N, Scotto N, Verma S, Lin NU; DESTINY-Breast12 study group. Harbeck N, et al. Among authors: muller v. Nat Med. 2024 Dec;30(12):3717-3727. doi: 10.1038/s41591-024-03261-7. Epub 2024 Sep 13. Nat Med. 2024. PMID: 39271844 Free PMC article. Clinical Trial.
[Mycoses].
Müller VL, Nenoff P, Mayser P. Müller VL, et al. Dermatologie (Heidelb). 2025 Sep;76(9):521-522. doi: 10.1007/s00105-025-05559-0. Epub 2025 Sep 5. Dermatologie (Heidelb). 2025. PMID: 40911049 German. No abstract available.
ASCO 2020.
Bartsch R, Dieras V, Cortes J, Müller V, Ruhstaller T. Bartsch R, et al. Among authors: muller v. Breast Care (Basel). 2020 Aug;15(4):433-436. doi: 10.1159/000510051. Epub 2020 Jul 16. Breast Care (Basel). 2020. PMID: 32982656 Free PMC article. No abstract available.
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer.
Denkert C, Schneeweiss A, Rey J, Karn T, Hattesohl A, Weber KE, Rachakonda S, Braun M, Huober J, Jank P, Sinn HP, Zahm DM, Felder B, Hanusch C, Teply-Szymanski J, Marmé F, Fehm T, Thomalla J, Sinn BV, Stiewe T, Marczyk M, Blohmer JU, van Mackelenbergh M, Schem C, Staib P, Link T, Müller V, Stickeler E, Stover DG, Solbach C, Metzger-Filho O, Jackisch C, Geyer CE Jr, Fasching PA, Pusztai L, Nekljudova V, Untch M, Loibl S. Denkert C, et al. Among authors: muller v. Cell Rep Med. 2024 Nov 19;5(11):101825. doi: 10.1016/j.xcrm.2024.101825. Cell Rep Med. 2024. PMID: 39566464 Free PMC article. Clinical Trial.
OMW: Leishmaniasis.
Müller VL, Vidakovic M, Kreuter A, Sunderkötter C, von Stebut E. Müller VL, et al. Dermatologie (Heidelb). 2025 Apr;76(4):230. doi: 10.1007/s00105-025-05481-5. Dermatologie (Heidelb). 2025. PMID: 40035838 German. No abstract available.
S1-Guideline Sebaceous Carcinoma.
Utikal J, Nagel P, Müller V, Becker JC, Dippel E, Frisman A, Gschnell M, Griewank K, Hadaschik E, Helbig D, Hillen U, Leiter U, Pföhler C, Krönig L, Ziemer M, Ugurel S. Utikal J, et al. Among authors: muller v. J Dtsch Dermatol Ges. 2024 May;22(5):730-747. doi: 10.1111/ddg.15405. Epub 2024 Apr 28. J Dtsch Dermatol Ges. 2024. PMID: 38679790
Erratum zu: OMW: Leishmaniasis.
Müller VL, Vidakovic M, Kreuter A, Sunderkötter C, von Stebut E. Müller VL, et al. Dermatologie (Heidelb). 2025 Jun;76(Suppl 1):17. doi: 10.1007/s00105-025-05501-4. Dermatologie (Heidelb). 2025. PMID: 40272477 German. No abstract available.
OMW: Candida-Spezies.
Müller VL. Müller VL. Dermatologie (Heidelb). 2025 Oct;76(10):639. doi: 10.1007/s00105-025-05572-3. Dermatologie (Heidelb). 2025. PMID: 40879715 German. No abstract available.
1,749 results